Project snapshot: Development of a stable-side test for Hendra virus
Hendra virus (HeV) is a lethal pathogen of major concern to the equine industry in eastern Australia. Currently, conclusive diagnosis of HeV is only possible...
45 pages
Published: 31 Aug 2005
Author(s): Whalley, J M
Download report PDF
DownloadPurchase a hard copy - AUD $45.00
This report describes development towards potential new vaccines for EHV-1. Firstly the immunogenicity of a formulation containing EHV-1 envelope glycoproteins was tested by measuring antibody responses of mares and young foals. Secondly, in order to provide a system whereby these and other vaccines could be assessed, an experimental EHV-1 respiratory challenge model of infection was established in mares and foals, using an Australian isolate of EHV-1. This model was then used to determine whether the immune responses to the glycoprotein formulation could provide protection against EHV-1 infection.